Literature DB >> 7711509

Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males.

R E Kilpatrick1, S Seiler-Smith, S N Levine.   

Abstract

Thyrotoxic periodic paralysis (TPP) is an unusual complication of a fairly common disease affecting mostly Asian males. In the United States, there have been several reports of TPP in different ethnic populations and it appears that the incidence is approximately one-tenth of that found in Asian countries. Only six reports of TPP in African-Americans could be found in the literature; however, we are reporting four cases diagnosed within a 13-year period at our institution. We conclude that TPP may occur more often in Blacks than previously suspected and should be considered when patients present with unexplained hypokalemia, muscular weakness and rhabdomyolysis. The epidemiology, clinical manifestations, pathophysiology, and treatment of TPP are reviewed.

Entities:  

Mesh:

Year:  1994        PMID: 7711509     DOI: 10.1089/thy.1994.4.441

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

Review 1.  Hypokalaemic paralysis.

Authors:  S K Ahlawat; A Sachdev
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

Review 2.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

3.  Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Authors:  S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

4.  A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants.

Authors:  Chin-Chun Chang; Chih-Jen Cheng; Chih-Chien Sung; Tzong-Shi Chiueh; Chien-Hsing Lee; Tom Chau; Shih-Hua Lin
Journal:  Eur J Endocrinol       Date:  2013-10-01       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.